Objective. To improve pain management practices, we developed an online interactive continuing education (CE) program for primary care providers (PCPs). This program follows the flow of clinical decisionmaking through simulated cases at critical pain treatment points along the pain treatment continuum.
Introduction
Chronic pain is one of the most prevalent medical conditions in the United States, affecting approximately 100 million people at any given time [1] , with a financial burden of somewhere between $565-$635 billion annually and a significant impact on overall quality of life. The use of opioid analgesic therapy may sometimes be an appropriate component of a treatment plan to manage chronic noncancer pain when other treatment modalities have not been successful [2] ; however, with the increase of prescribing opioid analgesics for the treatment of chronic noncancer pain, addiction, misuse, and abuse have also emerged as major public health problems in the United States. In 2010, it was reported that more than 35 million Americans age 12 and older have used an opioid analgesic for nonmedical purposes at some time in their life-an increase from about 30 million in 2002 [3] .
An analysis in 2009 reported that the majority of opioid analgesics prescribed for patients were prescribed by clinicians in primary care, family practitioners, or internists [4] , not pain specialists. Moreover, 41% of clinicians in one survey reported that pain specialists were not a financially accessible resource (i.e., an affordable resource) for their chronic noncancer patients [5] . Primary care providers find that chronic pain management is often challenging [6] , and their lack of confidence and ability to treat these patients may leave many patients with poorly treated or untreated chronic pain [7] .
One way to balance the risks of opioid addiction, misuse, and abuse against provider reluctance and undertreatment is to educate primary care providers about safe and effective prescribing of opioid analgesic therapy [8] . A recent study of 117 medical training programs in North America found that only 4% of them have an established curriculum about managing pain [9] , which is a significant deficit given that more pain specialty training is associated with less reluctance to prescribe opioids [10] ; health care providers consistently report that they are dissatisfied with the amount of training they have received in pain management [11] . Limited medical school and residency education about chronic pain and its management may be associated with a lack of confidence in prescribing opioid analgesics for patients with chronic noncancer pain among medical residents [12] . In addition, surveys of primary care providers indicate that many are reluctant to prescribe opioids because of concerns such as potential abuse, addiction, adverse effects, and development of tolerance [13] [14] [15] . Five specific dimensions of physician concerns were recently identified through a factor structure analysis of data from 1535 physicians [16] : impediments and concerns, including side effects; perceived effectiveness of opioids; schedule II vs III opioids, including legal concerns; medical education; and tamperresistant formulations of opioids and dosing.
Several studies have demonstrated that virtual patient learning approaches are well received and improve cognitive skills compared with traditional methods. For instance, medical students who used virtual patients to learn about acute back pain rated the learning experience more enjoyable and performed better on post-test examinations than students who read journal articles on the same topic [17] . A study assessing student attitudes in a pediatric clinical curriculum (Project LIVE) showed that students reported higher confidence in their ability to recognize abnormal findings when using hybrid CD-ROM/Internet virtual patients (either face to face or as a virtual group) than those in a traditional problem-based learning session [18] .
For this study, we used virtual patient learning approaches to develop and test a new online interactive pain management continuing education (CE) program: Managing Addiction and Pain in Primary Care (MAP-PC). This program was intended to teach chronic pain management practices to primary care providers and also address their concerns about treating pain and addiction. The purpose of this study was to test the efficacy of the MAP-PC to increase knowledge and improve attitudes and behaviors of primary care providers prescribing opioid medications for chronic noncancer pain and managing addiction compared with an active control condition.
Methods
All consent forms and assessments for this study were reviewed and approved by the New England Institutional Review Board on July 22, 2013.
Efficacy Trial

Participants
The inclusion criteria for study participants were 1) that they provided treatment for patients with chronic noncancer pain in the last 90 days; 2) active practice as a primary health care provider (MD or DO, physician in training [resident or fellow], nurse or nurse practitioner, or a physician's assistant); and 3) active Drug Enforcement Agency (DEA) registration to prescribe opioid medications. The exclusion criteria included: 1) not being actively engaged in pain treatment in a primary care setting (e.g., does not treat pain patients or refers all pain patients); 2) belonging to a professional organization for pain specialty (e.g., American Pain Society); 3) participation in a continuing education activity in the preceding 12 months related to opioid management/ chronic opioid therapy; and 4) holding credentials as an expert in pain treatment, as evidenced by any or all of the following: taking referrals as a pain specialist, board certification in pain management, caring for patients in a pain specialty clinic setting, and/or teaching in a pain residency or fellowship program.
This study utilized a rolling recruitment model. Participants were recruited between September 2013 and October 2013. Participants were recruited through flyers, e-mails, and face-to-face meetings at collaborating hospitals and pain conferences, and through the PainEDU.org website and weekly PainEDU newsletter. PainEDU is a free, nonpromotional online pain education website for primary care providers that was created and is maintained by Inflexxion, Inc. Potential participants received a description of the purpose and study tasks; then they were directed a link to a screening form to assess eligibility. Interested participants completed the screening form and, if eligible, were linked directly to the online consent form.
Assessments were administered through the online data collection software Verint Enterprise 7.0 [19] and stored Online Pain Management Education in a secure database. Participants received $75 for the baseline and post (one month postbaseline) assessments and $150 for the three-month follow-up (four months postbaseline).
Procedures
A randomized clinical trial was conducted to test the efficacy of the MAP-PC program. Within one week of the participants completing the baseline assessment, they were randomized into one of two educational study conditions: 1) online MAP-PC modules or 2) existing online CE courses. During the randomization, experience in clinical practice (less than five years vs five or more years) and percentage of pain patients (less than 20% vs 20% or more) were used in the block randomization algorithm to ensure that these potentially confounding factors were equally distributed across conditions. In addition, 54 physicians were randomly selected from the total sample to conduct a test-retest reliability substudy on the Pain Practice Behaviors Scale (PPBS) developed for this study. These participants were asked to complete the PPBS again three days postbaseline.
Conditions
First, core lessons were developed for experimental pain management education using the results of group concept mapping procedures with data from 16 nationally known experts in primary care, pain management, and addiction [20] . Then, existing CEs that covered the same materials were identified for use as the active control. The content of the lessons in both conditions focus on different aspects of safe and appropriate prescribing of opioid analgesics in a primary care setting for the treatment of noncancer pain: assessment, appropriate patient selection, initiating therapy, and monitoring, with a specific focus on patients who may be at high risk of aberrant drug-related behaviors (e.g., abuse, misuse, and addiction). The format of lessons was different between conditions. Unlike the text-based content in the active control condition, MAP-PC content 1) included case-based, interactive standardized patient simulation, 2) was presented along the continuum of care, and 3) was designed to have practical relevance to PCPs.
Experimental
Managing Addiction and Pain in Primary Care is an immersive, standardized patient simulation-type, casebased CE program about the management of chronic pain and addiction in a primary care setting. This course follows the flow of clinical decision-making through simulated cases at critical pain treatment points along the pain treatment continuum: 1) "The Fundamentals of Safe Opioid Prescribing Practices" covers initial assessment and patient selection; 2) "Managing Opioid Therapy in Patients with Chronic Pain and Comorbid Conditions" includes how to initiate an opioid therapy trial and how to incorporate patient differences (e.g., comorbid conditions) into a comprehensive treatment plan; 3) "The Role of Extended-Release/Long-Acting Opioids in Chronic Pain Management" describes the process of selecting an opioid formulation (short-acting/ immediate-release vs long-acting/extended-release); 4) "Prescribing Opioids Safely in Clinical Practice" covers key follow-up processes for a patient on an opioid regimen such as monitoring and re-assessment; and 5) "Pain Treatment Dilemmas, Roadblocks, and Communication with Chronic Pain Patients" exposes providers to problematic or challenging cases and how to navigate these difficult situations. Having the course follow the continuum of care provides the education in a logical and longitudinal sequence that would mirror the chronology of the clinical experience, thereby providing the most real learning environment possible for providers. Additionally, although recommended in this order, the lessons are also created to be self-contained if the learner wanted to focus on a particular area of interest.
To increase engagement and information retention, virtual patient scenarios were used to simulate cases that are difficult to experience in a real clinical environment. This instructional method has four clear advantages over the treatment of "live" patients: 1) In a single lesson, it can present the care of a pain patient over a longitudinal course, for example, five "virtual" months during which they present with periods of acute pain, misuse of medication, and other clinical problems to the clinician. 2) Virtual patient simulations can provide practice in responding to relevant clinical dilemmas, for example, a patient who comes to an appointment under the influence of drugs.
3) The user can practice responses in sensitive situations such as communicating with a patient who is adamant about receiving specific or a high dosage of opioids. Lastly, 4) the use of virtual patient simulation provides immediate feedback and the potential for learning through repetition. Being able to receive immediate feedback is important because it can be used to address providers' misconceptions and to remediate errors or poor clinical decisions as they occur. For these reasons, virtual patient simulation learning offers substantial potential for the training of key skills for treating pain patients. When available online, such training can be offered with greater accessibility and flexibility to potential users.
MAP-PC utilizes a multimedia approach toward opioid risk assessment and pain management through videos from pain and addiction experts, as well as intermittent motivational surveys, to increase interaction with the material that is presented. The cases in each lesson were designed to increase the self-efficacy of the learner by showing them that they can successfully navigate the challenges associated with chronic pain and addiction along with using opioid analgesic therapy safely and effectively when indicated.
Participants in the experimental condition were asked to access the MAP-PC educational modules via the Internet at their own pace and complete four modules within a one-month time frame. It was estimated that each module would take between 30 and 60 minutes for participants to complete. Participants were advised to complete one module each week. Progress on the lessons for the experimental participants was tracked through an online reporting system; in addition, participants were asked to track the dates they completed each lesson and record this on the postsurvey. Three months into the study, participants in this condition also completed one booster module on pain treatment dilemmas and effective communication with patients from the MAP-PC program.
Active Control
The active control condition completed modules that were chosen from existing free CE websites such as Medscape and Pain Clinician. As noted above, these modules covered pain management topics similar to the MAP-PC curriculum (e.g., assessment and treatment of chronic pain, safe opioid use practices) but were a representation of the typical CE format, which is a textbased style, not case-based or interactive. Also unlike MAP-PC, the topics were not presented along the continuum of care.
The CE activities selected were all beyond the accredited expiration date to ensure that the control participants did not incur additional benefits from participation in this study. These activities were recent enough to make sure the content was still timely regarding the subject matter. In addition, to control for potential dosage effects, this condition was also given in four online modules to complete at the participant's own time pace, with each module taking between 30 and 60 minutes to complete.
The active control participants were asked to notify the research coordinator when they completed each module and to report the dates they completed each module on the postsurvey. Reminders were also sent out to participants to complete the four modules within a onemonth time frame. Three months into the study, the active control participants were given one expired CME booster module on opioid prescribing effects and overdose risk.
Measures
This study measured knowledge, attitudes, and behaviors of the prescribers, along with demographic and satisfaction questions pertaining to the intervention. Both experimental and control condition participants completed all measures at three time points (baseline, one month postbaseline, and four months postbaseline), except for the demographics scale (baseline only) and the practice behaviors scale described below (baseline and four months postbaseline only). The latter was not administered at one-month follow up because it asks about practice behaviors in the last 90 days. A 90-day recall period was selected to be inclusive of practitioners who may have seen patients with pain less frequently than the past 30 days.
Participants provided background information such as gender, race/ethnicity, and age, prescriber-specific information such as years in practice, and pain-specific questions such as level of experience with pain treatment and percentage of chronic pain patients in their practices. Providers were also asked about their comfort level and reluctance toward prescribing opioids for chronic noncancer pain on a Likert scale of 1 to 5, where 1 ¼ not comfortable at all to 5 ¼ extremely comfortable, and 1 ¼ never reluctant to 5 ¼ always reluctant.
Knowledge about pain management was measured with the KnowPain-50 [21] . This 50-item survey assesses physician knowledge, attitudes, and beliefs regarding 1) initial pain assessment, 2) defining goals and expectations of a pain treatment plan, 3) developing the pain treatment plan, 4) implementing a treatment plan, 5) reassessing and managing longitudinal care, and 6) managing environmental issues. Each item is rated on a six-point Likert scale where 0 ¼ strongly agree and 5 ¼ strongly disagree. The KnowPain-50 demonstrated high internal consistency in all tested physician populations (a ¼ 0.77-0.85) and was correlated with physician behaviors.
The Clinicians' Attitudes about Opioids Scale (CAOS) [16] is a 39-item scale (total score alpha ¼ 0.87) that assesses five dimensions, including 1) impediments and concerns (alpha ¼ 0.89; item example: My negative experience with prescribing opioids for long periods of time for chronic noncancer pain has led me to change my prescribing practices), 2) perceived effectiveness (alpha ¼ .87; item example: Opioids are effective in controlling chronic noncancer pain), 3) schedule II vs III opioids (alpha ¼ 0.81; item example: I prefer schedule III to schedule II opioids), 4) medical education (alpha ¼ 0.83; item example: My education regarding pain evaluation and treatment during medical school was appropriate), and 5) tamper-resistant formulations and dosing (alpha ¼ .62; item example: I would be more likely to prescribe opioids if TRF formulas were available). Items were evaluated on a 0 ¼ strongly disagree to 10 ¼ strongly agree scale. The CAOS has good testretest reliability of between 0.62 and 0.78 for each subscale.
The Pain Practice Behaviors Scale was developed for this study to measure the behaviors of pain practitioners who have experience working with chronic noncancer pain patients who are appropriate candidates for or are currently being treated with opioid therapy. This scale was created through multiple iterations of testing including development, expert review and user testing, pilot testing, cognitive pretesting, and a test-retest analysis as part of the field trial. This 31-item scale is separated into three subscales, where items posed are conditional upon the clinician having had the opportunity to practice certain preventive behaviors. Clinicians are asked to rate how often they or a member of their treatment team employed the following practice behaviors in the last 90 days on a five-point Likert scale, where 1 ¼ never, 2 ¼ rarely, 3 ¼ sometimes, 4 ¼ often, and 5 ¼ always. The three subscales are 1) behaviors demonstrated before prescribing opioids (17 items), 2) behaviors during follow-up visits with patients who are currently using opioids (7 items), and 3) behaviors when a patient may not be taking their opioids as prescribed (7 items). A mean score per subscale was computed by adding up the scores per item in each subscale and then dividing by the number of items in that subscale. A total mean PPBS score was also computed. Cronbach's alphas for the baseline scores were 0.92 for subscale 1 (started a patient on an opioid regimen), 0.81 for subscale 2 (follow-up procedures), and 0.81 for subscale 3 (suspected aberrant drug-related behavior).
Statistical Analysis
The overall design of the study was 2 x 3 factorial mixed design, repeated-measures model comparing the experimental (MAP-PC) with the active control condition in changes in the primary outcomes over time (baseline, one month postbaseline, and four months postbaseline for knowledge and attitudes; baseline to four months postbaseline for behaviors).
Data analyses were carried out in the following steps: 1) computing descriptive statistics for all demographic variables and testing for differences in demographics between conditions (experimental vs active control) at baseline; 2) testing for mean differences between conditions (experimental vs active control) over time on each outcome; 3) conducting qualitative comparisons of outcomes for the experimental and active control conditions (% change over time); and 4) conducting exploratory analyses for moderation effects. To test the internal consistency of each scale, Cronbach's alphas were computed using baseline data from all study participants. To confirm the existence of one factor for the new 31-item behaviors scale, a principal components analysis with Varimax rotation was conducted on the PPBS baseline data. In addition, a test-retest analysis was performed on the PPBS data of 54 randomly selected physicians from each condition three days postbaseline. All analyses except the principal components analysis were performed using SAS, version 9.3. The principal components analysis was performed using SPSS, version 22.
Each model included the following fixed effects: 1) condition (experimental vs active control), 2) time (baseline, one month postbaseline and four months postbaseline for knowledge and attitude outcomes or baseline and four months postbaseline for behaviors), and 3) condition-BY-time. The model treated time as a repeated measures variable to allow for covariation across time points. Statistical focus of these analyses was on the interaction effect, condition-BY-time, as this effect tests differences between conditions over time. When a condition-BY-time fixed effect was statistically significant, post hoc contrasts were conducted to test for differences between conditions on mean change from baseline to postintervention (one month) and baseline to three months postintervention (i.e., four months postbaseline).
In addition, exploratory moderating analyses were performed to evaluate whether MAP-PC was more effective for various demographic subgroups (e.g., more than five years of experience prescribing opioids vs five or fewer years of experience prescribing opioids, physicians vs nonphysician providers). Models for testing for moderating effects included all previously mentioned fixed effects (condition, time, condition-BY-time), as well as four additional effects (moderator, condition*moderator, time*moderator, condition*time*moderator).
We fit linear mixed models using the SAS GLIMMIX procedure. An unstructured covariance matrix was applied to the residuals in all models; other correlation matrices (e.g., compound symmetry) returned comparable results. For the models where the interaction effect of interest was significant, post hoc tests were conducted with the LSMESTIMATE statement; P values reported for these post hoc comparisons have been corrected for type I error using a well-established simulation method [22] .
Results
Participant Characteristics
The baseline demographic characteristics of the study population are presented in Table 1 . A total of 238 individuals participated in the study. Of these, 48.7% (N ¼ 116) were randomized to the control and 51.3% (N ¼ 122) were randomized to the experimental condition. See the CONSORT flow diagram in Figure 1 . Most of the primary care providers were physicians (70.6%). Other care providers included nurse practitioners (NPs; 22.3%) and physicians' assistants (PAs; 7.1%). There were no significant demographic differences between the two study conditions. Completion of the education modules was measured for each condition, with 70% of the experimental participants and 84% of the control participants completing all four modules; the significantly (P ¼ 0.011) lower completion rate in the experimental group suggests that the interactive experimental condition was more demanding than the text-based control group condition.
Pain Practice Behavior Scale
Factor analysis: The factor analysis of baseline PPBS data from the whole sample indicated that all of the items loaded 0.456 or higher on the first component. The first component explained 42% of the variance in the model (see Table 2 ).
Reliability analyses: Results from the PPBS test-retest subsample (N ¼ 54) indicated that this new scale has good test-retest reliability: 0.93 for subscale 1, 0.76 for subscale 2, 0.85 for subscale 3, and 0.86 for the total mean score.
Treatment Effects
Primary Outcomes
Linear mixed models were run to ascertain whether the participants in the experimental condition, as compared with participants in the control condition, evidenced a significantly greater mean change over time in clinicians' knowledge, attitudes, and behaviors related to opioid prescribing. Results are presented in Table 3 . Both experimental and control conditions demonstrated improvements over time (i.e., statistically significant time effects) in knowledge, attitudes, and behaviors related to opioid prescribing. For example, the mean for the total score for knowledge significantly increased over time in both the control condition (150.99 at baseline to 161.25 at four months postbaseline) and the experimental condition (152.57 at baseline to 159.98 at four months postbaseline). No differences by conditions over time were observed for the primary outcomes except for the tamper-resistant formulation (TRF) and dosing subscale (TRF) of the CAOS. The experimental condition exhibited significantly greater change over time in the TRF scale compared with the control condition (F 2, 236 ¼ 3.89, P ¼ 0.02). Post hoc comparisons suggested that there was change in the TRF scale from baseline to postbaseline assessment (t ¼ 2.53, P ¼ 0.012), and from baseline to three-month follow-up after the onemonth intervention (i.e., four months postbaseline; t ¼ 2.28, P ¼ 0.023) for experimental participants, as compared with the control participants (Table 3) . Post hoc comparisons also suggested that, while the control condition did not show a change in attitudes toward TRFs (19.33 at baseline to 19.99 at four months postbaseline), the experimental condition was less likely to endorse opioid TRFs over time (19. 73 at baseline to 18.65 at four months postbaseline).
Because this subscale of the CAOS exhibited suboptimal internal consistency (Cronbach's alpha ¼ 0.45), we conducted an exploratory examination of itemlevel responses among the experimental condition on the three-item TRF subscale. Results indicated little change over time in agreement with the statement "I would be more likely to prescribe opioids if TRF formulations were available" (experimental condition: baseline mean ¼ 6.74, four-month postbaseline mean ¼ 6.67). In contrast, there was a reduction in agreement with the items "I would prescribe an opioid TRF formulation over a non-TRF formulation for my patients even if it was more expensive" (experimental condition: baseline mean ¼ 5.99, four-month postbaseline mean ¼ 5.49) and "I would try to prescribe TRF over the non-TRF formulation only for those patients with higher abuse potential" (experimental condition: baseline mean ¼ 7.0, four-month postbaseline mean ¼ 6.48). 
Secondary Outcomes
Linear mixed models were run to ascertain whether the participants in the experimental condition, as compared with participants in the control condition, evidenced a mean change over time for discomfort (i.e., lack of confidence) and reluctance related to opioid prescribing. Results are presented in Table 3 . For both the experimental and control conditions, there was a significant time effect demonstrating decreased discomfort and reluctance over time. For example, the mean for discomfort prescribing opioids significantly decreased over time in both the control condition (1.74 at baseline to 1.55 at four months postbaseline) and in the experimental condition (1.75 at baseline to 1.60 at four months postbaseline).
Moderation Analyses
Moderation analyses were run to determine if there were differences in knowledge, attitudes, and behaviors between physicians and nonphysicians (NPs or PAs) across the control and experimental conditions. Results are presented in Table 4 . A condition-BY-time-BY-discipline effect was found for two of the subscales: the impediments and concerns subscale of the CAOS (F 2, 234 ¼ 3.5, P ¼ 0.032) and potentially aberrant drug behaviors (PPBS subscale 3) over time (F 1, 186 ¼ 5.11, P ¼ 0.025).
Post hoc comparisons indicated that there was change over time in impediments and concerns from baseline to postbaseline (t ¼ 34.01, P < 0.0001) and from baseline to four months postbaseline (t ¼ 33.68, P < 0.0001). Physicians in the experimental condition showed the greatest significant reduction of their concerns over time compared with the physicians in the control condition.
Post hoc tests showed that, although all primary care providers improved their behaviors related to potentially Other than the time main effects shown with * above and the time by condition interaction for the tamper-resistant formulations and dosing scale (P ¼ 0 ¼ 02), there were no significant main effects or interactions. *Significant change over time (P < 0.05). † In order to evaluate confidence as an outcome variable, the five-point Likert scale was reduced to two categories because of limited numbers of cases in the "extremely comfortable" and "not comfortable at all" categories. The two categories were 1 ¼ "comfortable," including "extremely comfortable" and "very comfortable," and 2 ¼ "not comfortable," including "somewhat, not very, and not at all comfortable." The same structure was also used for reluctance with 1 ¼ "less reluctant," including "never, rarely, or sometimes reluctant," and 2 ¼ "more reluctant," including "often or always reluctant." ‡ Unique superscripts indicate significant pairwise post hoc tests for time by condition interaction (P < 0.05). There were other interactions for a few variables that were not presented, such as condition by time, condition by discipline, and discipline by time. *Significant change over time by condition by discipline (P < 0.05). † Unique superscripts indicate significant pairwise post hoc tests for time by condition by discipline interaction (P < 0.05).
aberrant drug-related behaviors, the nonphysicians (i.e., NPs and PAs) in the experimental condition were most likely to improve prescribing practices from baseline to one-month follow-up (t ¼ -28.54, P < 0.0001) and from baseline to four months postbaseline (t ¼ 35.64, P < 0.0001) when compared with nonphysicians in the control condition.
Discussion
We developed an online interactive continuing education program on pain management practice for primary care providers that follows the flow of clinical decisionmaking through simulated cases at critical pain treatment points along the pain treatment continuum. Using a randomized controlled trial, we tested the efficacy of this program, Managing Addiction and Pain in Primary Care, by comparing it against online CE courses covering similar topic areas but presented in the typical textbased style. Unlike previous studies [17, 18] , access to interactive pain management education via MAP-PC did not significantly improve provider's knowledge, attitudes, and behaviors over time compared with the active control condition. Participants in both conditions increased their pain practice behaviors, reduced their negative attitudes, and reduced their reluctance and discomfort to safely utilize these medications in their practice for patients who need them. Moreover, there were higher completion rates in the active control condition (textbased) vs experimental condition (case-based, interactive), suggesting a preference for a more straightforward (i.e., quicker) learning experience. Perhaps these participants were responsive to a "packaged," chronologic, and clinically meaningful curriculum in this topic area.
The one significant difference between the experimental and control participants on the primary outcomes was their attitudes toward using tamper-resistant formulations of opioid analgesics in their practices. A study by Turk et al. [23] showed that practitioners with higher concerns about prescribing were more likely to prescribe TRFs. This may be because they are uncomfortable with prescribing opioids and think that TRFs are safer alternatives requiring less consideration regarding aberrant drug-related behaviors. In our study, experimental participants continued to endorse the prescribing of TRFs over time, but they did so with less frequency than the control condition. Perhaps experimental clinicians, posteducation, were better able to understand the role of TRFs and better identify the limitations of their expertise, when to refer, and how to comanage the "difficult patient," etc., and therefore were not dependent on TRFs to limit potential opioid abuse by their patients. Furthermore, research suggests that TRFs are replaced with other drugs by those who are inclined to abuse them [24] , making them a less attractive solution for pain management practice in general.
Recent literature indicates that provider characteristics such as sex, race, and age are associated with pain management decisions [25] . Further exploratory analyses were conducted to identify if provider characteristics were significant moderators of the outcomes at follow-up. We hypothesized that discipline (e.g., whether the participant was a physician or an NP or PA), may affect the primary outcomes because of their different training and education regimens as well as experiences on a daily basis. Two differences were found for knowledge, attitudes, and behaviors between disciplines. On the attitudes scale, physicians in the experimental condition had greater reduction of concerns than physicians in the control condition on the impediments and concerns subscale of the CAOS. This could be a result of the case-based format of the MAP-PC education program. These cases are designed to increase selfefficacy of the learner by showing them that they can successfully treat patients with chronic pain using opioids. This curriculum was specifically conceptualized for primary care physicians [20] , and consequently the content and delivery method is most relevant to this population.
Another discipline-related finding was that nonphysicians in the experimental condition showed the most improvement in following recommended behaviors for responding to aberrant drug behaviors compared with all other conditions. Nurse practitioners and physicians' assistants are closer to the front line, and they may see more requests for early refills and have to vet these requests as they come in before they are seen by a doctor, so they may have been more likely to implement this newly acquired education.
There is significant support for the effectiveness of continuing medical education programs on physician behavior in the literature [26] , but as recently stated by Dr. Loeser in a Pain Medicine commentary [27] , ""Although we live in the era of evidence-based medicine, there are few controlled trials on how to educate pain providers, nor are there likely to be many in the future."" This is one of the first randomized controlled trials to corroborate the idea that education can make a difference regarding these outcomes in the area of pain practice management. Additionally, this study showed that the more clinically relevant the education content is to the provider and the closer it is to their daily practice, the more potential it has to create a positive effect.
There were several limitations in this study. Due to study feasibility issues, the outcomes measures were selfreport, not direct observation of physicians implementing pain practices. We used an active control condition looking at CEs that covered the same topics as the experimental condition, and participants were not blinded to condition. As no primary outcomes showed differences between conditions but all participants showed improvements in knowledge, attitudes, and behaviors, this study did not establish the superiority of an interactive approach in opioid education; perhaps given the similarity of the content between the conditions, the sample size was not sufficient to identify significant differences for modality. Further, these improvements on our outcome variables may be due to selection bias as those interested in pain education may have been more likely to participate in this study. Additionally, participants within our study may have shared information between conditions or conducted independent online searches for additional content on this topic.
Future research of pain management programs could assess change in attitudes toward patients, as well as prescribing practices. For example, 30% of respondents in one study of physicians reported derogatory descriptions of patients with chronic noncancer pain [12] . According to Upshur [11] , Providers likely will also need training in patient-centered care approaches that address the compliance and behavioral problems they perceive as so problematic.
Conclusion
The goals of the Decade of Pain Control and Research (2001-10) have yet to be met. There is still a deficit about pain management and addiction education for health care providers in this country [28, 29] that may contribute to a reluctance to use opioid analgesics even when indicated, leading to possible undertreatment of patients with chronic noncancer pain. This speaks to the necessity of having easily accessible, quality, comprehensive training along the continuum of care in pain management designed to impact attitudes as well as prescribing practices. Given the results of this study, we recommend that CE programs for primary care providers in pain management cover topics clinically relevant to the needs of providers in primary care settings.
